Skip to navigation Skip to content

Covid-19: Pooled testing among recommendations to fix test, trace and isolate system

In a series of recommendations to fix the struggling Covid-19 test, trace and isolate system in England, health researchers from University College London and the London School of Hygiene & Tropical Medicine say that pooled testing for Covid-19 could significantly increase testing capacity in a relatively short space of time and help with the identification of asymptomatic cases in key workers. Writing in the Journal of the Royal Society of Medicine, the researchers say that evaluating samples in batches rather than individually, and re-testing only the groups that come up positive means fewer tests overall would be needed. Several countries, including China, USA, Germany, Portugal, New Zealand, Rwanda, Uruguay, Israel and Vietnam have used pooled testing to considerably increase testing capacity and decrease pressure on lab reagents and operators.

As positivity rates rise, however, pooling becomes less efficient because more samples have to be tested. Co-author Alex Crozier, from the Division of Biosciences at University College London, said: “We are close to missing that window of opportunity in England unless we can control transmission quickly. For now, pooling may be best reserved for surveillance testing and asymptomatic screening of healthcare workers, care homes and hospital pre-admissions.”

As well as increased investment in NHS and Public Health England labs to scale up additional testing locally and making use of unused lab capacity in universities and research institutes where possible, the recommendations include the initiation of environmental surveillance by testing wastewater as an early warning system for Covid-19 outbreaks.

The authors also recommend a major investment in people on the ground to support contact tracing. Pointing to Massachusetts where a $44 million contact tracing programme hired and trained 1,000 people to support existing local public health volunteers, the researchers write that this approach is much less costly than the UK government’s £100 billion ‘Operation Moonshot’, and has reached 91.8% of cases and 78.8% of contacts. Recognising the important role played by superspreading events, another of the recommendations is to increase resources to enable a greater focus on identifying clusters using retrospective tracing, as seen in several countries that have been most successful such as Japan, South Korea, and Uruguay.

Another of the authors, Professor Martin Mckee, of the London School of Hygiene & Tropical Medicine, said: “England stands on the edge of a precipice: find, test, trace, isolate and support strategies need to be re-thought to have any chance of avoiding a considerable rise in cases over the coming months requiring a return to stricter social distancing measures nationwide. Our recommendations are feasible, do not require further individual sacrifice and would likely have a significant impact on driving down the reproductive number and reducing the socio-economic impact of the pandemic if they were implemented quickly.”

Notes to editors

Fixing England’s COVID-19 response: learning from international experience (DOI: 10.1177/0141076820965533) by Alex Crozier, Martin Mckee and Selina Rajan will be published by the Journal of the Royal Society of Medicine at 00:05 hrs (UK time) on Friday 16 October 2020.

The link for the full text version of the paper when published will be: https://journals.sagepub.com/doi/full/10.1177/0141076820965533

For further information or a copy of the paper please contact:

Rosalind Dewar
Media Office, Royal Society of Medicine
DL: +44 (0) 1580 764713
M: +44 (0) 7785 182732
E: media@rsm.ac.uk

The Journal of the Royal Society of Medicine (JRSM) is a leading voice in the UK and internationally for medicine and healthcare. Published continuously since 1809, JRSM features scholarly comment and clinical research. JRSM is editorially independent from the Royal Society of Medicine, and its editor is Dr Kamran Abbasi.

JRSM is a journal of the Royal Society of Medicine and it is published by SAGE Publishing.

Sara Miller McCune founded SAGE Publishing in 1965 to support the dissemination of usable knowledge and educate a global community. SAGE is a leading international provider of innovative, high-quality content publishing more than 1000 journals and over 800 new books each year, spanning a wide range of subject areas. A growing selection of library products includes archives, data, case studies and video. SAGE remains majority owned by our founder and after her lifetime will become owned by a charitable trust that secures the company’s continued independence. Principal offices are located in Los Angeles, London, New Delhi, Singapore, Washington DC and Melbourne. www.sagepublishing.com

Skip to top